Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy
Journal of Gynecologic Oncology · 2025 · 36 (6)
DOI: 10.3802/jgo.2025.36.e99 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Thomas Bartl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Gynecology and Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Chemoradiotherapy, Neoplasms, Second Primary. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
OBJECTIVE: Systemic chemotherapy in recurrent cervical cancer is a palliative treatment approach with limited oncologic outcome. As emerging evidence supports favorable prognosis following radical local treatment strategies for oligometastatic recurrence in gynecologic malignancies, there is an unmet clinical need to define prognostic implications of surgical metastasectomy in recurrent cervical cancer. METHODS: Data of 139 consecutive cervical cancer patients, who underwent primary external-beam radiotherapy with concomitant chemotherapy, followed by magnetic resonance image-guided adaptive brachytherapy between 2015 and 2019, was analyzed. Oncologic outcomes of recurrence patterns, defined according to the European Society for Radiotherapy and Oncology (ESTRO) and the American Society for Radiation Oncology (ASTRO) consensus, was assessed according to the type of recurrence therapy. RESULTS: Of 54 patients (38.8%) with metachronous disease recurrence, 21 (38.8%) classified as metastatic and 22 (40.7%) as oligometastatic. Oligometastatic recurrence was associated with improved progression-free survival after recurrence (PFS2; hazard ratio [HR]=2.95; 95% confidence interval [CI]=1.23-7.08; p=0.015) and disease-specific survival after recurrence (HR=3.28; 95% CI=1.40-7.70; p=0.006) irrespective of the type of recurrence therapy. An exploratory subgroup analysis of oligometastatic patients undergoing surgical resection ± adjuvant therapy (n=12) suggested reduced risk of second disease recurrence (odds ratio=0.15; 95% CI=0.02-0.92; p=0.020) and improved PFS2 (HR=0.24; 95% CI=0.06-0.99; p=0.048) as compared to palliative systemic treatment (n=7). CONCLUSION: A relevant number of recurrences qualifies as oligometastatic according to the ESTRO-ASTRO consensus, which associate with improved prognosis irrespective of the type of recurrence therapy. Patients experiencing oligometastatic recurrence should be carefully evaluated for potentially curative treatment approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of General Gynecology and Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
- Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.
- Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria. alina.sturdza@meduniwien.ac.at.
ORCID-Profile: Thomas Bartl, Tim Dorittke, Cristina Ciocsirescu, Johannes Knoth, Maximilian Schmid, Christoph Grimm, Alina Sturdza
Zitieren
APA
Bartl, T., Dorittke, T., Ciocsirescu, C., Knoth, J., Schmid, M., Grimm, C., & Sturdza, A. (2025). Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy. Journal of Gynecologic Oncology, 36(6). https://doi.org/10.3802/jgo.2025.36.e99
Vancouver
Bartl T, Dorittke T, Ciocsirescu C, Knoth J, Schmid M, Grimm C, et al. Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy. Journal of Gynecologic Oncology. 2025;36(6). doi:10.3802/jgo.2025.36.e99
BibTeX
@article{Bartl2025,
author = {Bartl, Thomas and Dorittke, Tim and Ciocsirescu, Cristina and Knoth, Johannes and Schmid, Maximilian and Grimm, Christoph and Sturdza, Alina},
title = {Oncologic outcome of metachronous oligometastatic recurrence in advanced cervical cancer patients after primary radio-chemotherapy},
journal = {Journal of Gynecologic Oncology},
year = {2025},
volume = {36},
number = {6},
doi = {10.3802/jgo.2025.36.e99}
}
EUVIMED